Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

ALXO FY 2018 Earnings — ALX Oncology Holdings Inc. Revenue & Financial Results | Market Cap Arena

ALXOALX Oncology Holdings Inc.

$113M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$187,0009.0% margin

Operating Income

-$14M-662.0% margin

Net Income

-$14M-664.3% margin

EPS (Diluted)

$-0.63

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$269,000

Balance Sheet

Total Assets

$11M

Total Liabilities

$2M

Stockholders' Equity

$9M

Cash & Equivalents

$8M

← Q1 2019 All Quarters